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Rheumatoid arthritis (RA) is a chronic inflammatory disease of autoimmune origin. Huo-luo-xiao-ling dan (HLXL) is an herbal
mixture that has been used in traditional Chinese medicine over several decades to treat chronic inflammatory diseases including
RA. However, the mechanism of the anti-arthritic action of this herbal remedy is poorly understood at the molecular level. In this
study, we determined by microarray analysis the effects of HLXL on the global gene expression profile of the draining lymph node
cells (LNC) in the rat adjuvant arthritis (AA) model of human RA. In LNC restimulated in vitro with the disease-related antigen
mycobacterial heat-shock protein 65 (Bhsp65), 84 differentially expressed genes (DEG) (64 upregulated and 20 downregulated)
versus 120 DEG (94 upregulated and 26 downregulated) were identified in HLXL-treated versus vehicle (Water)-treated rats,
respectively, and 62 DEG (45 upregulated and 17 downregulated) were shared between the two groups. The most affected pathways
in response to HLXL treatment included immune response, inflammation, cellular proliferation and apoptosis, and metabolic
processes, many of which are directly relevant to arthritis pathogenesis. These results would advance our understanding of the
mechanisms underlying the anti-arthritic activity of HLXL.
1. Introduction
Huo-luo-xiao-ling dan (HLXL) is an herbal formula based
on the principles of traditional Chinese medicine (TCM)
[1, 2]. HLXL has long been in use in China for the treatment
of a variety of inflammation-mediated disorders, including
rheumatoid arthritis (RA). We have previously reported
that HLXL can suppress ongoing experimental arthritis in
the rat, and this protective effect involved modulation of
antigen-induced immunological and biochemical mediators
ofinflammation[3–6].Multiplecellularandmolecularevents
involving different functional pathways drive the pathogen-
esis of arthritis [7, 8]. In this context, we reasoned that
examination of transcriptional events in the draining lymph
node cells (LNC) using microarrays and large-scale gene
expression analysis might be of help in determining concur-
rent changes in different effector pathways during disease as
well as following treatment. In fact, microarray analysis has
previously been employed to analyze the correlation of cold
and heat patterns with changes in gene expression in patients
with RA [9, 10] and to examine the effects of treatment of RA
with conventional antiarthritic drugs [11–13].
To gain an insight into the molecular events mediating
the beneficial effects of HLXL in adjuvant arthritis (AA),
we performed microarray gene expression profiling of the
LNC of rats treated with HLXL (experimental group) or
Water (control group). The choice of LNC is based on the
significance of the draining lymph nodes in the pathogenesis2 Evidence-Based Complementary and Alternative Medicine
of AA in the Lewis rats. The induction of AA after Mtb
injection involves the priming of potentially pathogenic T
cells within the draining lymph nodes, followed by the
migration of these primed T cells into the joints, leading
to the development of arthritis [14–17]. Furthermore, the
pathogenesis of arthritis involves not only lymphoid cells but
also myeloid-lineage cells [7, 8]. Therefore, we tested bulk
LNC instead of purified T cells.
2. Materials and Methods
2.1. Animals. Male Lewis (LEW/Hsd) (RT.1
l)r a t s( 5t o
6 weeks old) were obtained from Harlan Sprague-Dawley
(HSD) (Indianapolis, IN, USA) and then housed in the
animal care facility of the University of Maryland School of
Medicine,Baltimore,MD,USA.Allexperimentalprocedures
performed on these rats were in accordance with the guide-
lines of the Institutional Animal Care and Use Committee
(IACUC).
2.2. Huo-Luo-Xiao-Ling Dan (HLXL). HLXL used in this
study is a defined mixture of 11 herbs, and the constituents
of HLXL preparations used in those studies and the present
studywerethoroughlycharacterizedbyHPLCfingerprinting
asdescribedinourpreviousstudies[1–6].Thetoxicityassess-
ment of this herbal product has been described elsewhere
[1–3]. Our earlier studies indicated that HLXL (2.3g/kg, oral
feeding) has significant anti-inflammatory and antiarthritic
effects in the rat adjuvant arthritis (AA) model of human RA
[3–6].
2 . 3 .I n d u c t i o na n dG r a d i n go fA d j u v a n tA r t h r i t i s( A A )a n d
HLXL Treatment of Arthritic Rats. LEW rats were immu-
nized subcutaneously (s.c.) with 2mg/rat heat-killed M.
tuberculosisH37Ra(Mtb)(Difco,Detroit,MI,USA)in200𝜇L
of mineral oil (Sigma-Aldrich) at the base of the tail. At
the onset of arthritis, these rats were randomly divided
into two groups (experimental and control). HLXL was
suspended in Water and fed (2.3g/kg) to rats using a gavage
needle (FNC-16-3, Kant Scientific Corporation, Torrington,
CT, USA). The experimental group of rats (TH)w a sd a i l y
fed HLXL beginning within 24h of disease onset (d 10-11)
a n dt h e nc o n t i n u e df o r7d a y s .Th ec o n t r o lg r o u po fr a t s
(TW) received Water (the vehicle) by the same procedure.
Untreated arthritic rats (T0) served as controls for both TH
and TW. All rats were examined and graded regularly for the
severity of arthritis as described earlier [18].
2.4. LNC Culture and RNA Extraction. The draining lymph
nodes (LN) were harvested from HLXL-treated and vehicle
(Water-) treated arthritic LEW rats after 7 days of treatment
as described previously [4–6]. A single cell suspension of
LNC was cultured at 37
∘Cf o r2 4hi nas i x - w e l lp l a t e( 5×1 0
6
cells/well) in serum-free HL-1 medium (Lonza, Walkersville,
MD, USA) with or without Bhsp65 (5𝜇g/mL) [5, 19, 20].
Thereafter, total RNA was extracted from cells using Trizol
reagent(Invitrogen,Carlsbad,CA,USA)andfurtherpurified
using an affinity resin column (RNeasy Mini Kit, Qiagen
Ltd, Crawley, UK). The concentration and quality of RNA
were measured using NanoDrop ND-1000 (NanoDrop Tech-
nologies, Wilmington, DE, USA). The integrity and purity of
the total RNA and cRNA were analyzed using a Bioanalyzer
2100 andRNA kit6000LabChip(AgilentTechnologies).The
28S/18S ratio of total RNA ranged from 2.0 to 2.4, and RNA
integrity number (RIN) ranged from 8.3 to 9.5. This RNA
preparationwasthenusedforfurthergenerationofcRNAfor
testing in microarrays.
2.5. cRNA Synthesis and Probe Array Hybridization. The
biotin-labeled cRNA was synthesized according to the 2-
step amplification protocol outlined by the manufacturer
(Illumina) with 100ng of total RNA as input material. Then,
t h eb i o t i n - l a b e l e dp r o d u c tw a sh y b r i d i z e do n t oa nI l l u -
mina RatRef-12 Expression BeadChip (a genome-wide array
with 22,000 probes) for whole genome expression profiling
according to Illumina’s Direct Hybridization Assay protocol.
The assays were performed in the Biopolymer-Genomics
Core of UMB. Three independent experiments, that is, 3
gene chips/group of biological replicates, were performed.
Thereafter, the signal was scanned on iScan.
2.6. Microarray Data Analysis. The signal intensity was cal-
culated with the Illumina BeadStudio software. Expression
data were processed with GeneSpring (Agilent Technologies,
Santa Clara, CA, USA) for normalization and pair-wise
analysis. Briefly, data files (with the extension CEL) were
uploaded in the GeneSpring GX program and grouped.
Then the data was processed using the “Default Guided
Workflow” to calculate Robust Multiarray Average (RMA)
and Baseline Transformation to Median of all Samples. Also
performed was quality control (QC) for background check.
F o l l o w i n gt h a tt h el o w e s t2 0p e r c e n t i l eo fa l lt h ei n t e n s i t y
values on the raw signal values was filtered, and the analysis
for significance was performed by setting the cutoff limits
based on false discovery rate (FDR) and “fold change”. For
the gene expression profile in vitro in response to Bhsp65,
theexpressionlevelofgenesinducedbyBhsp65restimulation
of LNC was compared with that of the baseline (LNC
cultured in medium only). For analysis of ex vivo gene
expressionprofileofarthriticrats,thegeneexpressionofLNC
in medium of HLXL-treated (TH) and Water-treated (TW)
rats was compared. Furthermore, the expression profile of
untreated arthritic rats (T0 group) was compared separately
withTH/TW group.Thesignificance(𝑃value)ofdifferentially
expressed genes (DEG) was determined by unpaired 𝑡-test.
Fold change in gene expression >2.0 and 𝑃 value < 0.05
correctedwithBenjamin-Hochbergwereusedtoestimatethe
FDR as the threshold for identifying DEG. For comparing
theexpressionofDEGsharedbetweenTH and TW,ei th erex
vivo or in vitro, significantly modulated genes were selected
by setting 򳵻 fold change to >0.5.
2.7. Quantitative Real-Time PCR (qPCR). At o t a lo f1 𝜇g
of RNA used for the microarray analysis was reverse-
transcribed to cDNA using iScript cDNA synthesis kit
(Bio-Rad), and the resulting cDNA (1:10 dilution) wasEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: HLXL alters Bhsp65-induced gene expression in LNC. The draining lymph nodes were harvested from HLXL-treated (TH)a n d
vehicle (Water-) treated (TW) arthritic LEW rats after 7 days of treatment. The lymph node cells (LNC) were cultured in vitro with or without
Bhsp65. Thereafter, total RNA was extracted from cells and then used for further generation of cRNA for testing in microarrays. The gene
expression profiles of Bhsp65-restimulated LNC are represented by heat map (a) and Venn diagram (b). LNC cultured in medium alone (ex
vivo) served as the baseline for the Bhsp65-restimulated group. In heat map, red color indicates increased expression, whereas blue color
indicates reduced expression of genes compared with the level of the corresponding baseline gene expression. DEG were selected using as
cut-off fold change >2.0 and 𝑃 value < 0.05 corrected with Benjamin-Hochberg (Med: medium; Bhsp65: mycobacterial heat shock protein
65).
amplified and assayed by qPCR. For qPCR, SYBR Green
(PCR Master Mix, AB Applied Biosystems, Warrington,
UK) method was performed as previously described [19–21].
S p e c i fi cp r i m e r s( f o rs e l e c t e dg e n e ss u c ha sI L - 1 𝗽, Caspase11,
Ccl20,Ccr1,Ccr5,Cd25(IL-2r𝗼),Cxcl10,Lpl,MMP12,Socs1,
and Stat1) were designed according to the NCBI sequence
database using thesoftware PrimerExpression 2.0 fortesting
selected genes. Hypoxanthine-guaninephosphoribosyltrans-
ferase(HPRT)wasusedasthehousekeepingcontrol.AllPCR
reactions were performed in triplicate. Relative mRNA levels
for each sample were quantified using the 2
−򳵻򳵻𝐶t approach
and then normalized with respect to HPRT RNA as the
standard.
3. Results
3.1. Gene Expression Profile of LNC (Ex Vivo) of HLXL-
Treated, Vehicle-Treated, and Untreated (Control) Rats. Rats
with AA were treated with either HLXL or vehicle (Water)
for 7d. Thereafter, their draining LNC were subjected to
genomic analysis with the bead array system (Illumina).
No significant difference (𝑃 > 0.05) was found between
HLXL-treated (TH) and Water-treated group (TW), (data not
shown). However, a comparison of TH/ TW group each with
T0 group showed significant differences between TH and
TW (Table 1). The expression of 152 genes was significantly
altered when comparing TH and T0 groups. Of these 152
genes,theexpressionof7geneswasupregulated,whilethatof
145 genes was downregulated. In comparison, the expression
of 246 genes was significantly modulated when comparing
TW and T0 g r o u p s .O ft h e s e ,o n l y4g e n e sw e r eu p r e g u l a t e d .
Furthermore, 126 genes were shared between TW and TH.
VariousfunctionalgroupsofDEGaresummarizedinTable1.
3.2. Gene Expression Profile of Antigen-Restimulated
LNC (In Vitro)
3.2.1. Bhsp65-Induced Gene Expression Profile of Water-Treat-
ed (T𝑊)A r t h r i t i cR a t s .A total of 120 genes were differ-
entially regulated (≥2-fold and 𝑃 < 0.05)u p o na n t i g e n
restimulation of LNC in Water-treated rats [21], of which
94 were upregulated and 26 were downregulated (Figure 1).
The Gene Ontology classification of the DEG revealed 10
functional categories (Table 2). Based on their function, the
three major categories of genes include immune response-
relatedgenes(48genes,40%),cellproliferationandapoptosis
(17 genes, 14.2%), and genes with undefined function (25
genes, 21%). In the immune response-related genes, the 48
differentially expressed transcripts (Table 2)w e r el i n k e dt o
inflammation and chemotaxis, to the JAK-STAT cascade,
and to antigen processing and presentation. The genes
for three inflammatory cytokines, IL-1𝗽,I L - 1 𝗼, and IFN-
𝗾,s h o w e di n c r e a s e de x p r e s s i o nw i t hf o l dc h a n g eo f3 . 3 7 ,
2.43, and 10.73, respectively (Figure 2). The chemotaxis-
related genes included several upregulated genes such as
Cxcl10(18.46-fold),Ccl20(2.30-fold),Cxcl1(2.0-fold),Cxcl114 Evidence-Based Complementary and Alternative Medicine
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Figure2:ComparisonoftheBhsp65-inducedDEGinlymphoidcellsofHLXL-treatedandWater-treatedratswithAA.DEGwerecategorized
into subgroups according to their biological function as follows: (a) general immune activity; (b) antigen processing and presentation; (c)
metabolism; (d) other nonimmune related mechanisms involved in arthritis development: adhesion molecule (A), angiogenesis (B), bone
damage (C), cellular response to oxygen and oxidation-reduction (D), signal transduction and pathways (E), and autoimmune disease-
relevant antigen (F); (e) cell proliferation; (f) chemokines and receptors; (g) cytokines and receptors; and (h) proteins with binding activity
(e.g., binding to actin, DNA, etc.). The level of gene expression is presented as fold change above 2, and 𝑃 < 0.05.Evidence-Based Complementary and Alternative Medicine 5
T a b l e1 :Th eg e n ee x p r e s s i o np r o fi l e so fL N C( ex vivo) of HLXL-/Water-treated rats compared with Untreated rats.
Functional group Water-treated (Tw) HLXL-treated (TH)
Individual-DEG Shared-DEG Individual-DEG
Cell proliferation and apoptosis 24 33 3
Immune activity 16 13 3
Metabolism
Lipid metabolism 0 1 1
Oxidation-reduction 0 6 5
Other metabolic processes 5 4 0
Binding activity 14 9 2
Transporter 2 4 2
Signal transduction 2 4 0
Other function 7 5 0
Undefined function 50 47 10
Sub total 120 126 26
Total 246 152
The gene expression profile of Water-treated (Tw)o rH L X L - t r e a t e d( T H)g r o u pv e r s u st h a to fu n t r e a t e da r t h r i t i cr a t s( T 0). Functional category is based on
biological processes. DEGs were selected using as cut off fold change >2.0 and 𝑃 < 0.05 corrected with Benjamin-Hochberg.
Table 2: The gene expression profiles of Bhsp65-restimulated LNC of HLXL-treated and vehicle (Water)-treated rats.
Gene function HLXL-treated Water-treated
UR-DEG DR-DEG UR-DEG DR-DEG
Immune response-related 36 4 41 7
Cell proliferation and apoptosis 3 3 13 4
Binding activity 6 0 5 1
Metabolism
Lipid metabolism-related processes 6 2 6 2
Other metabolic processes 2 1 3 1
Undefined 7 6 19 6
A n g i o g e n e s i s 1111
Signal transduction and pathways 1 2 1 2
Autoantigen 0 0 1 0
Others 0 0 3 0
Transport 2 1 1 2
Sub-total 64 20 94 26
Total 84 120
UR: upregulated; DR: downregulated; DEG: differentially expressed genes. DEG in response to Bhsp65-restimulation of LNC were compared. The gene
expression profile of LNC cultured with Bhsp65 was compared with that of LNC in medium (med) using the cut off 𝑃 < 0.05 corrected with Benjamin-
Hochberg, fold change >2.0 as described in Section 2.6. The functional categories of these DEG were based on the main biological processes involving them.
(2.35-fold),andCcr5(2.98-fold)butonedownregulatedgene
Ccr1 (−2.42-fold). Also identified were genes relating to
protein lysis, and antigen processing and presentation were
identified. In the cell growth and proliferation category, DEG
were linked to DNA replication, RNA transcription, protein
translation, regulation of apoptosis and cell proliferation, and
posttranslational protein modification.
3.2.2. Bhsp65-Induced Gene Expression Profile of HLXL-
Treated (T𝐻)A r t h r i t i cR a t s . Microarray data analysis identi-
fied 84 genes that were differentially expressed in response to
Bhsp65 in HLXL-treated group (Figure 1,T a b l e2). Of these
84, most of the transcripts (64 genes, 76.2%) were upreg-
ulated, while a relatively smaller group of genes (20 genes,
23.8%)wasdownregulated.Asinthecontrolgroup,thegenes
associated with immune response (40 genes, 47.6%) formed
the major category in HLXL-treated group, followed by those
withundefinedfunction(13genes,15.5%)andmetabolism(11
genes, 13.1%). Compared to Water (vehicle), HLXL affected
specific genes in the same subgroupor the same gene (shared
DEG) but to a different extent quantitatively. For example,
HLXL treatment affected the category of immune response-
related genes (inflammation and cytokines, chemotaxis, the
JAK-STATcascade,andantigenprocessingandpresentation)
as also observed following treatment with Water (Figure 2).6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Verification of microarray data by qPCR. The expression
of IL-1𝗽, Caspase11, Ccl20, Ccr1, Ccr5, Cd25 (IL-2r𝗼), Cxcl10, Lpl,
MMP12,Socs1,andStat1identifiedthroughmicroarrayanalysiswas
further verified by qPCR. An analysis of the correlation between the
levels of gene expression determined by microarray and qPCR was
performed. The coefficient of correlation (𝑟
2) was 0.8671, which was
statistically significant (𝑃 < 0.05).
But besides IL-1𝗽,I L - 1 𝗼 and IFN-𝗾 were significantly modu-
lated by HLXL.IL-2r𝗼 was also upregulatedin HLXL-treated
group but not in control group.
3.2.3. Comparison of Bhsp65-Induced Gene Expression in
HLXL-Treated versus Water-treated Rats. Ac o m p a r i s o no f
thegeneexpressionprofilesofthetwogroupsofratsrevealed
threesetsofgenes(Figure1).Briefly,22genesweremodulated
mainly by HLXL, of which 19 were upregulated, but 3 were
downregulated. Another 58 genes were altered exclusively in
control rats. Of these, 49 showed increased expression, while
9 showed reduced expression. A set of 62 genes were shared
between the two groups. Of these, 45 were upregulated,
while 17 were downregulated. We then examined the relative
expression of specific genes grouped accordingly to the role
of their encoded proteins in particular immunobiological
processes (Figure 2) .Th i sa n a l y s i sr e v e a l e dm u l t i p l et a r g e t
geneswhoseexpressionwasdifferentiallyup-/downregulated
in HLXL-treated versus Water-treated rats. These genes
represent multiple processes involved in the pathogenesis
of arthritis, namely, general immune activity, cellular pro-
liferation, antigen processing and presentation, adhesion
molecules, chemokines and their receptors, cytokines and
their receptors, angiogenesis, bone remodeling, and signal
transduction and pathways.
3.3. Validation of Expression of Genes by qPCR. The qPCR
results supported the microarray data (Figure 3), with dif-
ferences only in the scale of estimated upregulation or
downregulation.Asignificantcorrelationwasobservedinthe
expression of 11 genes (described under Section 2.7)( 𝑟
2 =
0.8610, 𝑃 < 0.05).
4. Discussion
In our previous studies on testing HLXL in rats with AA,
we showed that HLXL suppressed the ongoing disease via
downregulation of proinflammatory cytokines (IL-1𝗽,I L -
6, IL-17, and IFN-𝗾), chemokines (RANTES, MCP-1, MIP-
1𝗼, and GRO/KC), and biomolecules involved in cartilage
a n db o n ed a m a g es u c ha sm a t r i xm e t a l l o p r o t e i n a s e( M M P )
[4–6]. However, these parameters represent only a small
proportionofmediatorsofvariouseffectorpathwaysinvolved
in the pathogenesis of arthritis. Furthermore, this limited
set of parameters cannot fully explain the mechanism of
actionofHLXLthatcontains11herbs.Microarray-basedgene
expression profiling has enabled us to explore the complex
biologicalprocessesregulatedatthetranscriptionallevel,and
therefore, it is an appropriate tool to study the antiarthritic
activity of HLXL.
Analysis of the gene expression profiles of LNC res-
timulated with Bhsp65 in vitro revealed several interesting
sets of DEG when comparing HLXL-treated versus Water-
treated groups. In contrast, no significant difference was
observed in gene expression profile of LNC tested ex vivo
(without Bhsp65 restimulation). The results of in vitro anal-
ysis shed light on alteration of gene expression in LNC
by HLXL. Downregulation of genes associated with anti-
gen processing and presentation was the most prominent
effect of HLXL treatment when compared to its vehicle
(Water). Furthermore, HLXL-mediated downregulation of
the expression of the costimulatory molecule CD40 suggests
reduced activation of T cells. This represents one of the
ways to correct the overactive immune activity in AA. After
activation, T cells proliferate leading to expansion of the T-
cell pool, followed by apoptosis of most of the activated T
cells. T-cell proliferation is an important process to mediate
effective immunity, but excessive proliferation accompanies
autoimmunity [22]. Our present work illustrates the abil-
ity of HLXL to downregulate immune cell activation and
proliferation in AA. Reduced expression of genes linked
to DNA replication (Mcm3 predicted), RNA transcription
(Mybbp1a, Bhlhb5 predicted, and Edf1), amino acid trans-
portation (Tars, Kars), translation or synthesis of protein
(Eif4a1, RGD1565900 predicted, RGD1561310 predicted, and
RGD1565117 predicted), posttranslational protein modifica-
tion and folding (Ube2c predicted, Fkbp3 predicted), pro-
/antiapoptosis (RGD1308697, Birc3), and cell differentiation
(Rnf114) affected by HLXL indicated the inhibitory role of
HLXL in antigen-induced cellular activation and prolifera-
tion.
Taken together, HLXL mainly targeted three pathways to
exert its function in inhibiting AA: first, by suppressing the
activation of immune cells; second, by inhibiting the prolif-
eration of immune cells; and third, by controlling the pro-
inflammatorycytokineIFN-𝗾.Th1cellsandthecharacteristic
cytokine (IFN-𝗾)s e c r e t e db yt h e mp l a yac r i t i c a lr o l ei nt h e
pathogenesis of RA [7]. In this context, downregulation of
IFN-𝗾 by HLXL is of significance.
No significant difference in gene expression profiles of
LNC tested ex vivo without antigenic restimulation was
observed when HLXL-treated group was compared withEvidence-Based Complementary and Alternative Medicine 7
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the dynamics of gene expression during the course of AA. In
the AA model, most significant changes in gene expression
occur during the incubation phase of AA, for example, on
d 7 after disease induction [19]. Thereafter, there is marked
reduction in gene expression, returning to the normal level
d u r i n gt h ep e a k( d1 8 )a n dr e c o v e r y( d2 5 )p h a s e so fA A .
In this study, the rats developed arthritis on d 12 and then
w e r et r e a t e dw i t hH L X Lo rv e h i c l ef o r7d .Th et i m ep o i n to f
d 19 equals the peak phase of AA, and by then, most of the
gene expression changes return to normal (baseline) levels.
ThismightexplainwhytheeffectbyHLXLwasnotdetectable
whenLNCweretestedexvivowithoutBhsp65restimulation.
Our results showed a protective effect of HLXL against
AA and demonstrated that HLXL treatment results in
changes in Bhsp65-induced gene expression in LNC com-
pared to Water treatment. Taken together, the major findings
in regard to HLXL-induced changes can be summarized
as follows: (a) The maximum changes were observed in
immune activity-related genes, including an overexpression
of innate/adaptive immune response genes and downregula-
tionofgenesinvolvedininflammatoryresponse,antigenpro-
cessing and presentation, costimulation, and IFN-𝗾 response
genes. (b) The expression of cell proliferation genes was
reduced coupled with increased expression of genes related
to apoptosis, which might be a protective response targeted
against pathogenic effector cells. (c) Alleviation of oxidation
stress response might be one of the protective mechanisms
of HLXL as supported indirectly by our results. (d) HLXL
treatment upregulated the expression of genes encoding
interleukin-2 receptor alpha (IL-2Ra; CD25) and suppressor
of cytokine signaling 1 (SOCS1). CD25 is component of
the multimeric IL-2 receptor that binds the cytokine IL-2,
whereas SOCS1 is a regulator of both Janus kinase/signal
transducer and activator of transcription (JAK/STAT) and
IFN-𝗾-STAT1 signaling pathways. Interestingly, both of these
molecules play an important role in the development, expan-
sion, and activity of CD4
+CD25
+Foxp3
+ regulatory T cells
(Treg)[23–26].Tregbelongtotwocategories,natural(thymic
derived) and induced (peripherally-derived) [23–26]. Treg
are effective suppressors of pathogenic effector T cells of
T helper 17 (Th17) and Th1 lineage, both of which have
been invoked in the pathogenesis of autoimmune arthritis
in different experimental models as well as patients with
RA. Natural Treg constitutively express CD25 and Forkhead
box p3 (Foxp3), whereas induced Treg express it along with
induction of Foxp3 expression when they develop from
CD4
+CD25
− T cells under appropriate conditions of T-
cellactivation[23–26].Theabove-mentionedHLXL-induced
changesalsorepresentthelikelymechanismsbywhichHLXL
exerts its antiarthritic effect in rats with AA. Further charac-
terization of these molecular pathways would be helpful in
advancing our understanding of the pathogenesis of arthritis
andinidentifyingnewprognosticbiomarkersaswellasnovel
therapeutic targets for RA.
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